← back to search

Eugenie Poirot

Columbia University · US
Area of research
Public Health, Environmental and Occupational Health · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Malaria Research and Control, Neonatal Health and Biochemistry, Pharmaceutical Quality and Counterfeiting, and Hemoglobinopathies and Related Disorders.
h-index
20
citations
1,631
works
56
NIH funding
primary concept
email

Recent publications

Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data
BMC Medicine 2022cited by 23position: middledoi
A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting—high coverage and safety, but no significant impact on transmission
BMC Medicine 2018cited by 55position: middledoi
Barriers to routine G6PD testing prior to treatment with primaquine
Malaria Journal 2017cited by 44position: middledoi
Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial
Clinical Infectious Diseases 2017cited by 37position: middledoi
Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial
The Lancet Infectious Diseases 2016cited by 98position: middledoi
Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania
Malaria Journal 2016cited by 52position: middledoi
Review of Mass Drug Administration for Malaria and Its Operational Challenges
American Journal of Tropical Medicine and Hygiene 2015cited by 248position: middledoi
The challenges of introducing routine G6PD testing into radical cure: a workshop report
Malaria Journal 2015cited by 80position: middledoi
Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants
PLoS ONE 2015cited by 30position: firstdoi
Mass drug administration for malaria
Cochrane Database of Systematic Reviews 2013cited by 168position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Jimee Hwang · Centers for Disease Control and Prevention5 papers (2013–2017)Ingrid Chen · University of California, San Francisco3 papers (2015–2017)Brian Greenwood · Harvard University2 papers (2015–2017)Lorenz von Seidlein · Nuffield Orthopaedic Centre2 papers (2015–2015)Benedikt Ley · University of South Florida2 papers (2015–2017)Anders Björkman · Sahlgrenska University Hospital2 papers (2016–2018)Dysoley Lek · Cambodia National Malaria Center2 papers (2015–2017) · 2 papers (2015–2017)Wasif Ali Khan · McGill University Health Centre2 papers (2015–2017)Irina Jovel · Karolinska Institutet2 papers (2016–2018)Andreas Mårtensson · Uppsala University2 papers (2016–2018)Kamala Thriemer · University of South Florida2 papers (2015–2017)Laurence Slutsker · National Center for Emerging and Zoonotic Infectious Diseases2 papers (2013–2015)Roland Gosling · University of London2 papers (2015–2016)S. Patrick Kachur · Columbia University2 papers (2013–2015)Ric N. Price · Pennsylvania State University2 papers (2015–2017) · 1 papers (2018–2018)Jean Louis Ndiaye · Université de Thiès1 papers (2017–2017) · 1 papers (2016–2016)Michael C. Sachs · University of Copenhagen1 papers (2018–2018)